Remote Blood Pressure Monitoring: An Innovative Intervention for Managing High Risk of Cardiac Diseases for Pregnant Women to Prevent Poor Maternal Outcomes

Researcher Information

Abstract

Pregnant women at high risk of cardiac disease encounter various challenges leading to poor maternal outcomes, and fatalities. Recent studies show how the rate of cardiac disease/hypertension susceptibility has increased to 33.9%, with an associated high rate of negative fetal outcomes of 15% to 17%. In addressing these concerns, researchers are actively exploring alternative treatment strategies for pregnant women at high risk of cardiac diseases, as standard treatment options have limited efficacy. Intriguingly, research points to the success of a new innovative treatment called Remote Blood Pressure Monitoring (RPM), a medical device that utilizes a cuff and sensors to monitor a patient’s vitals and promptly transmit readings to their physicians. A wide range of scholarly articles, including those from Stanford CVI, NIH, PubMed, and many others, were used to investigate and highlight the potential of the RPM as a preventive strategy for treating pregnant women at high risk of cardiac disease, as it can improve patient quality of life (QOL) and maternal outcomes. Bringing awareness to this cost-effective innovative technology is one of the many primary objectives for this specific research study.

Faculty Sponsors

Dr. Paul Slawek

Project Type

Event

Location

Alvin Sherman Library

Start Date

4-3-2024 12:30 PM

End Date

4-4-2024 1:30 PM

This document is currently not available here.

Share

COinS
 
Apr 3rd, 12:30 PM Apr 4th, 1:30 PM

Remote Blood Pressure Monitoring: An Innovative Intervention for Managing High Risk of Cardiac Diseases for Pregnant Women to Prevent Poor Maternal Outcomes

Alvin Sherman Library

Pregnant women at high risk of cardiac disease encounter various challenges leading to poor maternal outcomes, and fatalities. Recent studies show how the rate of cardiac disease/hypertension susceptibility has increased to 33.9%, with an associated high rate of negative fetal outcomes of 15% to 17%. In addressing these concerns, researchers are actively exploring alternative treatment strategies for pregnant women at high risk of cardiac diseases, as standard treatment options have limited efficacy. Intriguingly, research points to the success of a new innovative treatment called Remote Blood Pressure Monitoring (RPM), a medical device that utilizes a cuff and sensors to monitor a patient’s vitals and promptly transmit readings to their physicians. A wide range of scholarly articles, including those from Stanford CVI, NIH, PubMed, and many others, were used to investigate and highlight the potential of the RPM as a preventive strategy for treating pregnant women at high risk of cardiac disease, as it can improve patient quality of life (QOL) and maternal outcomes. Bringing awareness to this cost-effective innovative technology is one of the many primary objectives for this specific research study.